3 Stocks I Saw on T...
Health Care: Drugs
Cytori Therapeutics Inc. (CYTX: NASDAQ)
$2.13 0.05 | 2.40%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.08 |
| 52 Week High | 5.72 |
| 52 Week Low | 1.90 |
| Avg. Daily Vol. (Mil) | 0.44 |
| Beta (3 year) | 2.04 |
| Share Related Items | |
| Mkt Cap (Mil) | 122.07 |
| Shares Out (Mil) | 58.69 |
| Float (Mil) | 56.84 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.30 |
| Current Ratio | 3.70 |
| LT Debt/ Equity | 2.88 |
| Total Debt / Equity | 3.59 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 17.77 |
| Price/Book | 17.82 |
| Price/Cash Flow | -4.30 |
| Per Share Data | |
| Earnings | -0.54 |
| Sales | 0.12 |
| Book Value | 0.12 |
| Cash Flow | -0.48 |
| Business Summary | |
|---|---|
| Cytori Therapeutics, Inc. develops, manufactures and sells medical products to enable the practice of regenerative medicine. | |
| General Information | |
| 3020 Callan Road
San Diego, CA 92121 |
|
| www.cytoritx.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 128 | |
| CEO: Christopher J. Calhoun | |
| Short Interest | |
| Current Month (Mil) | 9.37 |
| Previous Month (Mil) | 9.36 |
| Short Interest Ratio (Days) | 30.20 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -60.50 |
| Return on Investments | -111.00 |
| Profitability | |
| Gross Margin | 67.10 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with CYTX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor6 Drug Stocks Unworthy of B...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- ContributorStem Cell Stocks
- Usermurphman Portfolio 1
- UserSUPRATRADE HOT STOCKS (BUY ...
Latest CYTX Headlines from TheStreet
- 8 Stocks Under $10 Soaring Higher 05.10.12 | 01:05 pm
- Tuesday's Top 10 Articles, Videos on TheStreet 02.07.12 | 01:02 pm
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
- Cytori Therapeutics Inc. (CYTX): Today's Featured Drugs Loser 09.29.11 | 04:09 pm
- Biotech Stock Mailbag: Mela Sciences 09.09.11 | 06:09 am
- Biotech Stock Mailbag: Cytori Therapeutics 05.20.11 | 07:05 am
- Cytori Therapeutics Inc. Stock Downgraded (CYTX) 05.10.11 | 06:05 am
- Cytori Stock Hits New 52-Week High (CYTX) 04.04.11 | 10:04 am
- Cytori Therapeutics Inc. Stock Upgraded (CYTX) 03.24.11 | 06:03 pm
Press Releases for CYTX
- Cytori Therapeutics Announces Independent Clinical Study Results In Breast Reconstruction Presented At The Association Of Breast Surgery Conference - Business Wire 05.17.11 | 05:05 am
- Catholic Healthcare West President/CEO Lloyd H. Dean To Join Cytori Therapeutics’ Board Of Directors - Business Wire 11.03.10 | 07:11 am
- Cytori Announces Exercise In Full Of Overallotment Option And Closing Of Public Offering Of Common Stock; Raises $19.3 Million In Net Proceeds - Business Wire 10.13.10 | 09:10 am
- Cytori Therapeutics Prices Public Offering Of Common Stock - Business Wire 10.08.10 | 08:10 am
- Cytori Therapeutics Proposes Common Stock Public Offering - Business Wire 10.07.10 | 04:10 pm
- Adipose-Derived Stem & Regenerative Cells Reduce Mortality, Improve Renal Function In Preclinical Acute Kidney Injury Study Data Published Today - Business Wire 10.05.10 | 08:10 am
- Cytori Extends Distribution Agreement With GE Healthcare; Key Focus On Research Market - Business Wire 09.16.10 | 07:09 am
- Cytori Therapeutics Announces Fall 2010 U.S. Conference Schedule - Business Wire 09.13.10 | 07:09 am
- Cytori Issued Celution® System Patent For Orthopedic & Spinal Disc Diseases - Business Wire 08.12.10 | 07:08 am
- Cytori’s PureGraft™ System Receives European Approval For Fat Grafting Procedures - Business Wire 07.29.10 | 08:07 am
Partner Headlines for CYTX
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.13.11 | 09:07 am
- Cytori Therapeutics: Sales Miss? Yes. Bad Quarter? No - Seeking Alpha 05.06.11 | 03:05 pm
- Some Hidden Gem Stocks That May Have High Returns! - AOL 04.05.11 | 07:04 pm
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- 9 Cheap Stocks Under $10 Making New Price Highs - Seeking Alpha 03.25.11 | 08:03 am
- Options Brief: Cytori Therapeutics (CYTX) - Benzinga 03.17.11 | 01:03 pm
- UPDATE 1-Cytori, Astellas Pharma sign $10 mln equity deal - Reuters 12.07.10 | 07:12 am
